What is Bio-Rad Laboratories, Inc.'s market cap?

Bio-Rad Laboratories, Inc. (BIO.B) has a market capitalization of $8.2B and trades on NYSE.

What is Bio-Rad Laboratories, Inc.'s revenue and profitability?

Bio-Rad Laboratories, Inc. generated $2.6B in trailing twelve-month revenue with net income of $168.8M, representing a net margin of 6.5%. Gross margin stands at 51.9%, with free cash flow of $357.2M. These figures are based on the Q1 2026 filing.

Who are Bio-Rad Laboratories, Inc.'s competitors?

Bio-Rad Laboratories, Inc.'s key competitors include Danaher, Abbott Laboratories, Becton Dickinson, and others. These companies compete in similar markets and product categories.

Who does Bio-Rad Laboratories, Inc. partner with?

Bio-Rad Laboratories, Inc.'s notable partners include Sartorius AG.

What subsidiaries does Bio-Rad Laboratories, Inc. have?

Bio-Rad Laboratories, Inc.'s subsidiaries include Dropworks, Inc., Curiosity Diagnostics, Sp. Z. o. o., Stilla Technologies.

Where is Bio-Rad Laboratories, Inc. headquartered?

Bio-Rad Laboratories, Inc. is headquartered in United States of America and employs approximately 8,030 people. It has been publicly traded since 1899.

Bio-Rad Laboratories, Inc.

BIO.B and BIO

Bio-Rad Laboratories is a multinational life science and clinical diagnostics company that develops, manufactures, and markets a broad portfolio of instruments, systems, reagents, and consumables.

Market cap

$8.17B+21.5%

Revenue$2.6B+1.9%Net income$168.8M+108%Free cash flow$357.2M+0.5%EPS (diluted)$5.81+108%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

April 30, 2026

Revenue$592.1MBeat by $784.1K EPS$1.89Miss by $0.12

Read the full report

Next report

Jul 30, 2026 (in a month)

Revenue estimate$624.8M

EPS estimate$1.78

Financials

Q1 2026

Income statement

See full

Revenue$592.1M+1.1%

Gross profit$309.4M+1.1%

Operating income$34.1M+43.9%

Net income-$527.1M-924%

EPS (diluted)-$19.55-954%

Balance sheet

See full

Cash & equivalents$509.0M-2.7%

Total debt$987.3M-28.4%

Total equity$6.9B+2.6%

Total assets$9.8B+2.8%

Cash flow

See full

Operating cash flow$108.1M-16.8%

CapEx$30.0M-12.8%

Free cash flow$78.1M-18.2%

Valuation & ratios

Valuation

See full

Market cap$7.56B+10.3%

Enterprise value$8.04B+4.2%

P/E44.8×—

P/S2.9×+0.2×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin8.8%-3.1pp

Net margin6.5%+3.4pp

FCF margin13.8%-0.2pp

Returns & leverage

See full

Return on equity2.5%+1.3pp

Debt / equity0.1×-0.1×

Current ratio3.2×-2.8×

Segments

By segment

See full

Clinical Diagnostics$363.6M+1.9%

Life Science$228.5M0.0%

All Other Segments--100%

By geography

See full

Europe$206.8M+3.5%

Asia Pacific$110.4M+6.1%

Americas$45.1M+13.3%

Competitors

By market cap

Thermo Fisher Scientific$172.66B

Abbott$153.99B

Danaher$125.40B

Becton, Dickinson and Company$39.7B

Agilent Technologies$35.9B

QIAGEN$7.6B

Bio-Rad Laboratories, Inc.$7.6B

QuidelOrtho Corporation$932.2M

By revenue growth

Agilent Technologies+9.1%

Abbott+6.6%

Becton, Dickinson and Company+6.4%

Danaher+4.0%

Thermo Fisher Scientific+2.4%

Bio-Rad Laboratories, Inc.+1.9%

By net margin

Agilent Technologies19.55%

Thermo Fisher Scientific15.19%

Danaher14.89%

Abbott13.91%

Bio-Rad Laboratories, Inc.6.52%

Becton, Dickinson and Company5.33%

Profile

Bio-Rad Laboratories is a multinational life science and clinical diagnostics company that develops, manufactures, and markets a broad portfolio of instruments, systems, reagents, and consumables. The company provides specialized tools for biological research and integrated diagnostic systems for clinical laboratories, focusing on standardized laboratory workflows and reproducible test results. Its value proposition centers on a large installed base of systems that drive significant recurring revenue through the ongoing sale of test kits and consumables.

Competitive position

Bio-Rad is a leading global provider in the life science and clinical diagnostics markets, leveraging a massive portfolio of thousands of products and a significant installed base to maintain a competitive advantage through integrated workflows.

GeographiesUnited States, Europe, Asia Pacific, Americas

Customer segmentsAcademic and research institutions, Clinical laboratories, Biopharmaceutical companies, Government agencies

Business modelRazor-and-blade, Manufacturing, Recurring revenue, Direct sales

SuppliersChemical and biological material suppliers, Electronic component manufacturers, Machined metal and optical part suppliers, Cloud-based IT service providers

CustomersUniversity research labs, Hospital clinical labs, Commercial diagnostic labs, Biotech and pharma R&D departments, Food safety testing facilities

CountryUnited States of America

Listed1899

Employees8.0K

SectorLABORATORY ANALYTICAL INSTRUMENTS

IndustryLABORATORY ANALYTICAL INSTRUMENTS

Websitebio-rad.com

FilingsSEC EDGAR

Ask your AI about Bio-Rad Laboratories, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s market cap?: Bio-Rad Laboratories, Inc. (BIO.B) has a market capitalization of $8.2B and trades on NYSE.
What is Bio-Rad Laboratories, Inc.'s revenue and profitability?: Bio-Rad Laboratories, Inc. generated $2.6B in trailing twelve-month revenue with net income of $168.8M, representing a net margin of 6.5%. Gross margin stands at 51.9%, with free cash flow of $357.2M. These figures are based on the Q1 2026 filing.
Who are Bio-Rad Laboratories, Inc.'s competitors?: Bio-Rad Laboratories, Inc.'s key competitors include Danaher, Abbott Laboratories, Becton Dickinson, and others. These companies compete in similar markets and product categories.
Who does Bio-Rad Laboratories, Inc. partner with?: Bio-Rad Laboratories, Inc.'s notable partners include Sartorius AG.
What subsidiaries does Bio-Rad Laboratories, Inc. have?: Bio-Rad Laboratories, Inc.'s subsidiaries include Dropworks, Inc., Curiosity Diagnostics, Sp. Z. o. o., Stilla Technologies.
Where is Bio-Rad Laboratories, Inc. headquartered?: Bio-Rad Laboratories, Inc. is headquartered in United States of America and employs approximately 8,030 people. It has been publicly traded since 1899.